Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Open Access
- 31 May 2020
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 8 (11) , e14434
Abstract
Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone FGF23, and anemia, elevated FGF23, and serum phosphate are all significant risk factors for chronic kidney disease (CKD) pati...Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01‐HL145528, T32‐HL007910)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (F32‐AR065389, R21‐AR059278)
- National Institute of Diabetes and Digestive and Kidney Diseases (F31‐DK122679, R01‐DK112958)
This publication has 31 references indexed in Scilit:
- Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction modelJournal of Pharmacological Sciences, 2020
- Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKDJCI Insight, 2019
- Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancerHypoxia, 2017
- HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyondNature Reviews Nephrology, 2015
- Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in ratsAmerican Journal of Physiology-Renal Physiology, 2014
- Cellular and molecular mechanisms in kidney fibrosisJournal of Clinical Investigation, 2014
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney DiseaseNew England Journal of Medicine, 2009
- Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKDJournal of the American Society of Nephrology, 2009
- Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and AnemiaNew England Journal of Medicine, 2006